FDA Approved: VIMPAT — Original Application (UCB, Inc.)

View source ↗

Summary

FDA approved VIMPAT (lacosamide) under Original Application by UCB, Inc., marking the initial approval for the treatment of partial-onset seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Vimpat (lacosamide)

Snippet

ORIG AP for VIMPAT (LACOSAMIDE)